Your browser doesn't support javascript.
loading
Endogenous TLR2 ligand embedded in the catalytic region of human cysteinyl-tRNA synthetase 1.
Cho, Seongmin; Kim, Sang Bum; Lee, Youngjin; Song, Ee Chan; Kim, Uijoo; Kim, Hyeong Yun; Suh, Ji Hun; Goughnour, Peter C; Kim, YounHa; Yoon, Ina; Shin, Na Young; Kim, Doyeun; Kim, Il-Kyu; Kang, Chang-Yuil; Jang, Song Yee; Kim, Myung Hee; Kim, Sunghoon.
Afiliación
  • Cho S; Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea.
  • Kim SB; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, South Korea.
  • Lee Y; Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea.
  • Song EC; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, South Korea.
  • Kim U; Infection and Immunity Research Laboratory, Metabolic Regulation Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea.
  • Kim HY; Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea.
  • Suh JH; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, South Korea.
  • Goughnour PC; Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea.
  • Kim Y; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, South Korea.
  • Yoon I; Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea.
  • Shin NY; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, South Korea.
  • Kim D; Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea.
  • Kim IK; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, South Korea.
  • Kang CY; Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea.
  • Jang SY; Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea.
  • Kim MH; Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea.
  • Kim S; Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea.
J Immunother Cancer ; 8(1)2020 05.
Article en En | MEDLINE | ID: mdl-32461342

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Receptor Toll-Like 2 / Aminoacil-ARNt Sintetasas / Inmunidad Celular / Inmunoterapia / Neoplasias Experimentales Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: J Immunother Cancer Año: 2020 Tipo del documento: Article País de afiliación: Corea del Sur

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Receptor Toll-Like 2 / Aminoacil-ARNt Sintetasas / Inmunidad Celular / Inmunoterapia / Neoplasias Experimentales Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: J Immunother Cancer Año: 2020 Tipo del documento: Article País de afiliación: Corea del Sur